NESS-0327

NESS-0327 is a drug used in scientific research which acts as an extremely potent and selective antagonist of the cannabinoid receptor CB 1 .

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

NESS-0327 is a drug used in scientific research which acts as an extremely potent and selective antagonist of the cannabinoid receptor CB 1 . It is much more potent an antagonist, and more selective for the CB 1 receptor over CB 2 , than the more commonly used ligand rimonabant, with a K i at CB 1 of 350fM (i.e. 0.00035nM) and a selectivity of over 60,000x for CB 1 over CB 2 .

Independently, two other groups have described only modest nanomolar CB 1 affinity for this compound (125nM and 18.4nM ). Also unlike rimonabant, NESS-0327 does not appear to act as an inverse agonist at higher doses, instead being a purely neutral antagonist which blocks the CB 1 receptor but does not produce any physiological effect of its own.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1370371240 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.